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Introduction:  Plasma membrane Ca2+-ATPase (PMCA) is a transmembrane 
enzymatic protein present in human neurons,  myocytes, and RBCs which plays a role 
in controlling cellular Ca2+ levels by regulating intracellular ATP.1  Inhaled anesthetic 
agents, such as isoflurane, affect transmembrane Ca2+ levels by inhibiting PMCA 
activity.2 However, the effect of isoflurane on the interaction between ATP and PMCA 
has not been studied. We hypothesized that the inhibitory effects of isoflurane on PMCA 
involve modulation of the interaction between ATP and PMCA. 
Methods:  RBC membranes (containing PMCA) were isolated from human subjects with 
a previously validated methodology using a calmodulin affinity chromatographic 
technique.3 The membranes were treated with isoflurane using human serum albumin 
as an intermediary with transfer occurring via a dialysis membrane. The treated 
membranes were then assayed for PMCA activity using the Malachite Green 
Colorimetric Assay. Activity of PMCA was determined by measuring the release of 
inorganic phosphate. Varying concentrations of ATP were used to determine the 
inhibitory effect on PMCA by isoflurane. 
 
Results:  Isoflurane inhibited basal and CaM-stimulated PMCA activity (nmol of 
inorganic phosphate per mg PMCA per minute) by 28.6% (P < 0.04) and 66.9% 
(saturating concentration of 300nM) (P < 0.02), respectively.  Significant inhibition of 
PMCA activity (77.7%) also occurred at CaM concentration as low as 2nM.  Isoflurane 
also inhibited PMCA activity at ATP concentrations between 10µM and 1000µM. 
Conclusion:  Isoflurane inhibited basal and calmodulin-stimulated PMCA activity. 
Significant inhibition of PMCA activity occurred at all concentrations of CaM and as low 
as 2nM. Isoflurane suppressed the Michaelis-Menton kinetics of PMCA activity as a 
function of ATP at concentrations from 10µM to 1000µM. 
Discussion: We showed for the first time that isoflurane decreases PMCA activity as a 
function of ATP concentration. We also illustrated that isoflurane decreases the ability of 
CaM to stimulate PMCA activity.  In addition, we introduced a novel physiologic delivery 
system for isoflurane using albumin as a surrogate transfer molecule. The concentration 
of isoflurane used for these experiments was not determined.  Due to difficulties in 
studying neuronal PMCA, the RBC isoform was used as a substitute. Further 
investigations could include exploring the direct effects of isoflurane on CaM and ATP 
using neuronal isoforms of PMCA, and ensuring clinically relevent concentrations of 
isoflurane. These data would suggest that a primary biochemical target for isoflurane 
neural inhibition is intracellular ATP via a direct effect on PMCA activity. 
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